Orito E, Fujiwara K, Kanie H, Ban T, Yamada T, Hayashi K. Quantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients. World J Gastroenterol 2012; 18(39): 5570-5575 [PMID: 23112549 DOI: 10.3748/wjg.v18.i39.5570]
Corresponding Author of This Article
Etsuro Orito, MD, PhD, Department of Gastroenterology, Nagoya Daini Red Cross Hospital, Myoken-cho 2-9, Showa, Nagoya 466-8650, Japan. orito@nagoya2.jrc.or.jp
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/